Patient-tailored biological drugs like Advanced Therapy Medical Products (ATMPs) fuel our hope for a permanent cure of oncological diseases. What special requirements do these sensitive commodities entail for logistics? And how can special speed transport networks contribute to overcoming these challenges in a scalable and yet economic way? Christian Schenk from time:matters shares his experiences in comparable markets and related industries.